Why We Exist
As evidenced by increasing rates of overdose deaths, societies the world over have found themselves ill-equipped and overburdened in managing and mitigating the growing addiction crisis. More solutions are required to support and improve existing recovery methods, in order to develop a treatment model rooted in innovation and contemporary scientific findings.
Merging the historically validated healing capacity of plant compounds with cutting edge biopharmaceutical research is now at the forefront of the challenge to address society’s most urgent challenge to create a healthy and stable society. Our research seeks to provide a new model of healing and treatment to those in need.
Several of Entheon Biomedical’s founders have endured personal experiences with loss of loved ones due to the absence of suitable treatment options for issues ranging from opiate addiction to treatment resistant depression. From this perspective, our core mission is to investigate, manufacture, and commercialize scientifically valid treatment options to address, ameliorate and treat the addiction crisis that is plaguing many of our very own families and the modern world at large.
"Entheon Biomedical believes that people suffering from life-inhibiting addiction disorders, should have access to all scientifically-validated treatment protocols, and is committed to the development and commercializing entheogenic, FDA, EMA and Health Canada approved medicines that address the mounting public crisis of addiction and substance-related disorders."
Timothy Ko, CEO